The NF-κB/Rel and IκB gene families: Mediators of immune response and inflammation

Journal of Molecular Medicine

Volumn 74, Issue 12, 1996, Pages 749-769

  Wulczyn, F Gregory ^a   Krappmann, Daniel ^a   Scheidereit, Claus ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

I B; NF B; Oncogenes; Signal transduction; Transcription factors

Indexed keywords

NUCLEAR FACTOR; TRANSCRIPTION FACTOR;

APOPTOSIS; GENE ACTIVATION; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATION; ONCOGENE; REVIEW; SIGNAL TRANSDUCTION; STRESS;

EID: 0029836595     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050078     Document Type: Review

References (252)

1. Nolan GP, Baltimore D (1992) The inhibitory ankyrin and activator Rel proteins. Curr Opin Genet Dev 2:211-220
2. Baeuerle PA, Henkel T (1994) Function and activation of NF-KB in the immune system. Annu Rev Immunol 12:141-179
3. Siebenlist U, Franzoso G, Brown K (1994) Structure, regulation and function of NF-κB. Ann Rev Cell Biol 10:405-455
4. Finco TS, Baldwin AS (1995) Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 3:263-272
5. Israel A (1995) A role for phosphorylation and degradation in the control of NF-κB activity. Trends Genet 11:203-205
6. Thanos D, Maniati T (1995) NF-κB: a lesson in family values. Cell 80:529-532
7. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S (1995) Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev 9:2723-2735
8. Sen R, Baltimore D (1986) Inducibility of the κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell 47:921-928
9. Kawakami K, Scheidereit C, Roeder RG (1988) Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-κB) that activates transcription from a human immunodeficiency virus type I promoter in vitro. Proc Natl Acad Sci USA 85:4700-4704
10. Baeuerle PA, Baltimore D (1989) A 65-κDa subunit of active NF-κB is required for inhibition of NF-κB by IKB. Genes Dev 3:1689-1698
11. Baeuerle PA, Baltimore D (1988) Activation of DNA-binding activity in an apparently cytoplasmatic precursor of the NF-κB transcription factor. Cell 53:211-217
12. Baeuerle PA, Baltimore D (1988) IκB: a specific inhibitor of the NF-κB transcription factor. Science 242:540-546
13. Zabel U, Baeuerle PA (1990) Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell 61:255-265
14. Link E, Kerr LD, Schreck R, Zabel U, Verma I, Baeuerle PA (1992) Purified IκBβ is inactivated upon dephosphorylation. J Biol Chem 267:239-246
15. Bours V, Villalobos J, Burd PR, Kelly K, Siebenlist U (1990) Cloning of a mitogen-inducible gene encoding a kappa B DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs. Nature 348:76-80
16. Ghosh S, Gifford AM, Riviere LR, Tempst P, Nolan G, Baltimore D (1990) Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell 62:1019-1029
17. Kieran M, Blank V, Logeat F, Vandekerckhove J, Lottspeich F, Le Bail O, Urban M, Kourilsky P, Baeuerle PA, Israel A (1990) The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62:1007-1018
18. Nolan GP, Ghosh S, Liou H-C, Tempst P, Baltimore D (1991) DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell 64:961-969
19. Ruben SM, Dillon PJ, Schreck R, Henkel T, Chen C-H, Maher M, Baeuerle P, Rosen CA (1991) Isolation of a rel-related human cDNA that potentially encodes the 65 kDa subunit of NF-κB. Science 251:1490-1493
20. Meyer R, Hatada EN, Hohmann HP, Haiker M, Bartsch C, Rothlisberger U, Lahm HW, Schlaeger EJ, van Loon AP, Scheidereit C (1991) Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha. Proc Natl Acad Sci USA 88:966-970
21. Neri A, Chang CC, Lombardi L, Salina M, Corradini P, Maiolo AT, Chaganti RS, Dalla-Favera R (1991) B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10 homologous to NF-κB p50. Cell 67: 1075-1087
22. Schmid RM, Perkins ND, Duckett CS, Andrews PC, Nabel GJ (1991) Cloning of an NF-κB subunit which stimulates HIV transcription in synergy with p65. Nature 352:733-736
23. Bours V, Burd PR, Brown K, Villalobos J, Sun P, Ryseck RP, Bravo R, Kelly K, Siebenlist U (1992) A novel mitogen inducible gene product related to p50/p105-NF-κB participates in transactivation through KB sites. Mol Cell Biol 12:685-695
24. Mercurio F, Didonato J, Rosette C, Karin M (1992) Molecular cloning and characterization of a novel Rel/NF-κB family member displaying structural and functional homology to NF-κB p50/p105 DNA. Cell Biol 11:523-537
25. Ruben SM, Klement JF, Coleman TA, Maher M, Chen C-H, Rosen CA (1992) I-Rel: a novel rel-related protein that inhibits NF-κB transcriptional activity. Genes Dev 6:745-760
26. Ryseck R-P, Bull P, Takamiya M, Bours V, Siebenlist U, Dobrzanski P, Bravo R (1992) RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol Cell Biol 12:674-683
27. Ip YT, Reach M, Engstrom Y, Kadalayil L, Cai H, Gonzalez-Crespo S, Tatei K, Levine M (1993) Dif a dorsal-related gene that mediates an immune response in Drosophila. Cell 75: 753-563
28. Dobrzanski P, Ryseck RP, Bravo R (1994) Differential interactions of Rel-NF-κB complexes with IκBα determine pools of constitutive and inducible NF-κB activity. EMBO J 13: 4608-4616
29. Grilli M, Chiu JJ, Lenardo MJ (1993) NF-κB and Rel: participants in an multiform transcriptional regulatory system. Int Rev Cytol 143:1-62
30. Ghosh G, van Duyne G, Ghosh S, Sigler PB (1995) Structure of NF-κB p50 homodimer bound to a κB site. Nature 373: 303-310
31. Müller CW, Rey FA, Sodeoka M, Verdine GL, Harrison SC (1995) Structure of the NF-κB p50 homodimer bound to DNA. Nature 373:311-317
32. Gilmore TD (1992) Role of rel family genes in normal and malignant lymphoid cell growth. Cancer Surveys 15:69-87
33. Ohno H, Takimoto G, McKeithan TW (1990) The candidate proto-oncogene Bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60:991-997
34. Haskill S, Beg AA, Tompkins SM, Morris JS, Yurochko AD, Sampson-Johannes A, Mondal K, Ralph P, Baldwin AS Jr (1991) Characterization of an immediate early-gene induced in adherent monocytes that encodes IκB-like activity. Cell 65: 1281-1289
35. Kidd S (1992) Characterization of the Drosophila cactus locus and analysis of interactions between cactus and dorsal proteins. Cell 71:623-635
36. Geisler R, Bergmann A, Hiromi Y, Nüsslein-Volhard C (1992) Cactus: a gene involved in dorsoventral pattern formation of Drosophila, is related to the IκB family of vertebrates. Cell 71:613-621
37. Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh S (1995) IκBβ regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573-582
38. Hatada EN, Nieters A, Wulczyn FG, Naumann M, Meyer R, Nucifora G, McKeithan TW, Scheidereit C (1992) The ankyrin repeat domains of the NF-κB precursor p105 and the proto-oncogene Bcl-3 act as specific inhibitors of NF-κB DNA binding. Proc Natl Acad Sci USA 89:2489-2493
39. Henkel T, Zabel U, vanZee K, Muller JM, Fanning E, Baeuerle PA (1992) Intramolecular masking of the nuclear localization signal and dimerization domain in the precursor for the p50 NF-κB subunit. Cell 68:1121-1133
40. Inoue J, Kerr LD, Kakizuka A, Verma IM (1992) IκBγ a 70 kDa protein identical to the C-terminal half of pi 110 NF-κB: a new member of the 1κB family. Cell 68:1109-1120
41. Rice NR, MacKichan ML, Israel A (1992) The precursor of NF-κB p50 has IκB-like functions. Cell 71:243-253
42. Naumann M, Wulczyn FG, Scheidereit C (1993) The NF-κB precursor p105 and the (proto)oncogene product Bcl-3 are IκB molecules and control nuclear translocution of NF-κB. EMBO J 12:213-222
43. Naumann M, Nieters A, Hatada EN, Scheidereit C (1993) NF-κB precursor p100 inhibits nuclear translocation and DNA binding of NF-κB/rel factors. Oncogene 8:2275-2281
44. Scheinman R I, Beg AA, Baldwin AS Jr (1993) NF-κB p100 (Lyt-10) is a component of H2TF1 and can function as an IκB-like molecule. Mol Cell Biol 13:6089-6101
45. Mercurio F, DiDonato JA, Rosette C, Karin M (1993) p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev 7:705-718
46. Liou H-C, Nolan GP, Fujita T, Baltimore D (1992) The NF-κB precursor p105 contains an internal IκB-like inhibitor that preferentially inhibits p50. EMBO J 11:3003-3009
47. Wulczyn FG, Naumann M, Scheidereit C (1992) The candidate protooncogene Bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB. Nature 358:597-599
48. Beg AA, Ruben SM, Scheinman RI, Haskill S, Rosen CA, Baldwin AS (1992) IκB interacts with the nuclear localization sequences of the subunit of NF-κB: a mechanism for cytoplasmic retention. Genes Dev 6:1899-1913
49. Ganchi PA, Sun SC, Greene WC, Ballard DW (1992) IκB/MAD-3 masks the nuclear localization signal of NF-κB p65 and requires the transactivation domain to inhibit NF-κB p65 DNA binding. Mol Cell Biol 3:1339-1352
50. Bork P (1993) Hundreds of ankyrin-like repeats in functionally diverse proteins: mobile modules that cross phyla horizontally. Proteins 17:363-374
51. Blank V, Kourilsky P, Israël A (1991) Cytoplasmatic retention, DNA binding and processing of the NF-κB p50 precursor are controlled by a small region in the C-Terminus. EMBO J 10:4159-4167
52. Zabel U, Henkel T, dos Santos Silva M, Baeuerle PA (1993) Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus. EMBO J 12:201-211
53. Beg AA, Baldwin AS Jr. (1993) The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev 7:2064-2070
54. Hatada EN, Naumann M, Scheidereit C (1993) Common structural constituents confer IκB-acytivity to NF-κB-p105 and IκB/MAD-3. EMBO J 12:2781-2788
55. Mellits KH, Hay RT, Goodbourn S (1993) Proteolytic degradation of MAD3 (IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB. Nucleic Acids Res 21:5059-5066
56. Naumann M, Scheidereit C (1994) Activation of NF-κB in vivo is regulated by multiple phosphorylations. EMBO J 13: 4597-4607
57. Donald R, Ballard DW, Hawiger J (1995) Proteolytic processing of NF-κB/IκB in human monocytes: ATP-dependent induction by pro-inflammatory mediators. J Biol Chem 270: 9-12
58. Bours V, Franzoso G, Azarenko V, Sun P, Brown K, Siebenlist U (1993) The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell 72:729-739
59. Nolan GP, Fujita T, Bhatia K, Huppi C, Lion HC, Scott ML, Baltimore D (1993) The Bcl-3 proto-oncogene encodes a nuclear IκB-like molecule that preferentially interacts with NF-κB p50 and p52 in a phosphorylation-dependent manner. Mol Cell Biol 13:3557-3566
60. Urban MB, Baeuerle PA (1990) The 65-kDa subunit of NF-κB is a receptor for IκB and a modulator of DNA-binding specificity. Genes Dev 4:1975-1984
61. Dobrzanski P, Ryseck RP, Bravo R (1995) Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100. Oncogene 10:1003-1007
62. Beg AA, Finco TS, Nantermet PV, Baldwin AS Jr. (1993) Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol Cell Biol 13:3301-3310
63. Brown K, Park S, Kanno T, Franzoso G, Siebenlist U (1993) Mutual regulation of the transcriptional activator NF-κB and its inhibitor IκBα. Proc Natl Acad Sci USA 90:2532-2536
64. Cordle SR, Donald R, Read MA, Hawiger J (1993) Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-κB proteins in human monocytic THP-1 cells. J Biol Chem 68:11803-11810
65. Henkel T, Machleidt T, Alkalay I, Kronke M, Ben-Neriah Y, Baeuerle PA (1993) Rapid proteolysis of IκBα is necessary for activation of transcription factor NF-κB. Nature 365:182-185
66. Kanno T, Brown K, Franzoso G, Siebenlist U (1994) Kinetic-analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-κB. Mol Cell Biol 14:6443-6451
67. Sun SC, Elwood J, Beraud C, Greene WC (1994) Human T-cell leukemia virus type I Tax activation of NF-κB/Rel involves phosphorylation and degradation of IκB alpha and RelA (p65)-mediated induction of the c-rel gene. Mol Cell Biol 14:7377-7384
68. Traenckner EB, Wilk S, Baeuerle PA (1994) A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκBα that is still bound to NF-κB. EMBO J 13:5433-5441
69. Lin YC, Brown K, Siebenlist U (1995) Activation of NF-κB requires proteolysis of the inhibitor IkBα: signal-induced phosphorylation of IκBα alone does not release active NF-κB. Proc Natl Acad Sci USA 92:552-556
70. Shirakawa F, Mizel SB (1989) In vitro activation and nuclear translocation of NF-κB catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol Cell Biol 9:2424-2430
71. Ghosh S, Baltimore D (1990) Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature 344:678-682
72. Finco TS, Beg AA, Baldwin AS Jr (1994) Inducible phosphorylation of IκBα is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors. Proc Natl Acad Sci USA 91:11884-11888
73. Miyamoto S, Maki M, Schmitt MJ, Hatanaka M, Verma IM (1994) Tumor necrosis factor α-induced phosphorylation of IκBα is a signal for its degradation but not dissociation from NF-κB. Proc Natl Acad Sci USA 91:12740-127444
74. Alkalay I, Yaron A, Hatzubai A, Jung S, Avraham A, Gerlitz O, Pashut-Lavon I, Ben-Neriah Y (1995) In vivo stimulation of IκB phosphorylation is not sufficient to activate NF-κB. Mol Cell Biol 15:1294-1301
75. DiDonato JA, Mercurio F, Karin M (1995) Phosphorylation of IκB alpha precedes but is not sufficient for its dissociation from NF-κB. Mol Cell Biol 15:1302-1311
76. Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, Ballard DW (1995) Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol Cell Biol 15:2809-2818
77. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U (1995) Control of IκBα proteolysis by site-specific signal-induced phosphorylation. Science 267:1485-1488
78. Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA (1995) Phosphorylation of human IκBα on serines 32 and 36 controls IκBα proteolysis and NF-κB activation in response to diverse stimuli. EMBO J 14:2876-2883
79. Whiteside ST, Ernst MK, LeBail O, Laurent-Winter C, Rice N, Israel A (1995) N- and C-terminal sequences control degradation of MAD3/IκBα in response to inducers of NF-κB activity. Mol Cell Biol 15:5339-5345
80. Davis NS, Ghosh S, Simmons DL, Tempst P, Liou HC, Baltimore D, Bose HR Jr (1991) Rel-associated pp40: An inhibitor of the rel family of transcription factors. Science 253: 1268-1271
81. Rice NR, Ernst MK (1993) In vivo control of NF-κB activation by IκBα. EMBO J 12:4685-4695
82. Miyamoto S, Chiao PJ, Verma IM (1994) Enhanced IκBα degradation is responsible for constitutive NF-κB activity in mature murine B-cell lines. Mol Cell Biol 14:3276-3282
83. Barroga CF, Stevenson JK, Schwarz EM, Verma IM (1995) Constitutive phosphorylation of IκBα by casein kinase II. Proc Natl Acad Sci USA 92:7637-7641
84. Rogers S, Wells R, Rechsteiner M (1986) Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234:364-368
85. Ciechanover A (1994) The ubiquitin-mediated proteolytic pathway: mechanisms of action and cellular physiology. Biol Chem Hoppe-Seyler 375:565-581
86. Jentsch S, Sehlenker S (1995) Selective protein degradation: a journey's end within the proteasome. Cell 82:881-884
87. Goldberg A L (1992) The mechanisms and functions of ATP dependent proteases in bacterial and animal cells. Eur J Biochem 203:9-23
88. Fan C, Maniatis T (1991) Generation of p50 subunit of NF-κB by processing of p105 through an ATP-dependent pathway. Nature 354:395-398
89. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T (1994) The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773-785
90. Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A, Ben-Neriah Y (1995) Stimulation-dependent IκBα phosphorylation marks the NF-κB inhibitor for degradation via ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 92: 10599-10603
91. Chen Z, Hagler J, Palombello VJ, Melandri F, Scherer D, Ballard D, Maniatis T (1995) Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev 9:1586-1597
92. Orian A, Whiteside S, Israel A, Stancovski I, Schwartz AL, and Ciechanover A (1995) Ubiquitin-mediated processing of NF-κB transcriptional activator precursor p105. Reconstitution of a cell-free system and identification of the ubiquitin-carrier protein E2 and a novel ubiquitin-protein ligase E3 involved in conjugation. J Biol Chem 270:21707-21714
93. Scherer DC, Brockman JA, Chen ZJ, Maniatis T, Ballard DW (1995) Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc Natl Acad Sci USA 92:11259-11263
94. Baldi L, Brown K, Siebenlist U (1996) Critical role for lysine 21 and 22 in signal-induced ubiquitin-mediated proteolysis of IκBα. J Biol Chem 271:376-379
95. Lin L, Ghosh S (1996) A glycine rich region in NF-κB p105 functions as a processing signal for the generation of the p50 subunit. Mol Cell Biol 5:2248-2254
96. Chen ZJ, Parent L, Maniatis T (1996) Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-862
97. Krappmann D, Wulczyn FG and Scheidereit C (1996) Different mechanisms control signal-induced degradation and basal turnover of the NF-κB inhibitor IκBα in vivo EMBO J (in press)
98. Li CC, Dai RM, Chen E, Longo DL (1994) Phosphorylation of NF-KB1-p50 is involved in NF-κB activation and stable DNA binding. J Biol Chem 269:30089-30092
99. Schmitz ML, dos-Santos-Silva MA, Baeuerle PA (1995) Transactivation domain 2 (TA2) of p65 NF-κB. Similarity to TA1 and phorbol ester-stimulated activity and phosphorylation in intact cells. J Biol Chem 270:15576-15584
100. Neumann M, Grieshammer T, Chuvpilo S, Kneitz B, Lohoff M, Schimpl A, Franza BR, Serfling E (1995) RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J 14:1991-2004
101. Schreck R, Baeuerle PA (1994) Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-κB. Methods Enzymol 234:151-163
102. Kopp E, Ghosh S (1994) Inhibition of NF-κB by sodium salicylate and aspirin. Science 265:956-959
103. Schulze-Osthoff K, Beyaert R, Vandevoorde V, Haegeman G, Fiers W (1993) Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J 12:3095-3104
104. Menon SD, Qin S, Guy GR, Tan YH (1993) Differential induction of nuclear NF-κB by protein phosphatase inhibitors in primary and transformed human cells. Requirement for both oxidation and phosphorylation in nuclear translocation. J Biol Chem 268:26805-26812
105. Scheidereit C, Krappmann D, Wulczyn FG (1996) Regulation of the NF-κB family of transcriptions factors by protein phosphorylation. In: M Clemens (ed) Protein phosphorylation and cell growth regulation. Harwood (in press)
106. Dominguez I, Sanz L, Arenzana Seisdedos F, Diaz-Meco MT, Virelizier JL, Moscat J (1993) Inhibition of protein kinase C zeta subspecies blocks the activation of an NF-κB-like activity in Xenopux laevis oocytes. Mol Cell Biol 13: 1290-1295
107. Diaz-Meco MT, Berra E, Municio MM, Sanz L, Lozano J, Dominguez I, Diaz Golpe V, Lain de Lera MT, Alcami J, Paya CV et al. (1993) A dominant negative protein kinase C zeta subspecies blocks NF-κB activation. Mol Cell Biol 13: 4770-4775
108. Lozano J, Berra E, Municio MM, Diaz-Meco MT, Dominguez I, Sanz L, Moscat J (1994) Protein kinase C zeta isoform is critical for κB-dependent promoter activation by sphingomyelinase. J Biol Chem 269:19200-19202
109. Montaner S, Ramos A, Perona R, Esteve P, Carnero A, Lacal JC (1995) Overexpression of PKCζ in NIH3T3 cells does not induce cell transformation nor tumorigenicity and does not alter NF-κB activity. Oncogene 10:2213-2220
110. Maran A, Maitra RK, Kumar A, Dong B, Xiao W, Li G, Williams BR, Torrence PF, Silverman RH (1994) Blockage of NF-κB signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. Science 265:789-792
111. Kumar A, Haque J, Lacoste J, Hiscott J, Williams BR (1994) Double-stranded RNA-dependent protein kinase activates transcription factor NF-κB by phosphorylating IκB. Proc Natl Acad Sci USA 91:6288-6892
112. Li S, Sedivy JM (1993) Raf-1 protein kinase activates the NF-κB transcription factor by dissociating the cytoplasmic NF-κB-IκB complex. Proc Natl Acad Sci USA 90:9247-9251
113. Finco TS, Baldwin AS Jr (1993) Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor KB requires Raf-1. J Biol Chem 268:17676-17679
114. Bruder JT, Heidecker G, Tan TH, Weske JC, Derse D, Rapp UR (1993) Oncogene activation of HIV-LTR-driven expression via the NF-κB binding sites. Nucleic Acids Res 21: 5229-5234
115. Diaz-Meco MT, Lozano J, Municio MM, Berra E, Frutos S, Sanz L, Moscat J (1994) Evidence for in vitro and in vivo interaction of Ras and protein kinase Cζ. J Biol Chem 269: 31706-31710
116. Anderson MT, Staal FJ, Gitler C, Herzenberg LA, Herzenberg LA (1994) Separation of oxidant-initiated and redox-regulated steps in the NF-κB signal transduction pathway. Proc Natl Acad Sci USA:91 11527-11531
117. Koong AC, Chen EY, Giaccia AJ (1994) Hypoxia causes the activation of nuclear factor κB through the phosphorylation of IκB alpha on tyrosine residues. Cancer Res 54:1425-1430
118. Neumann M, Tsapos K, Scheppler JA, Ross J, Franza BR Jr (1992) Identification of complex formation between two intracellular tyrosine kinase substrates: human c-Rel and the p105 precursor of p50 NF-κB. Oncogene 7:2095-2104
119. Klug CA, Gerety SJ, Shah PC, Chen YY, Rice NR, Rosenberg N, Singh H (1994) The v-abl tyrosine kinase negatively regulates NF-κB/Rel factors and blocks κ gene transcription in pre-B lymphocytes. Genes Dev 8:678-687
120. Frantz B, Nordby EC, Bren G, Steffan N, Paya CV, Kincaid RL, Tocci MJ, O'Keefe SJ, O'Neill EA (1994) Calcineurin acts in synergy with PMA to inactivate IκB /MAD3, an inhibitor of NF-κB. EMBO J 13 861-870
121. Fiers W (1991) Tumor necrosis factor: Characterization at the molecular, cellular and in vivo level. FEBS Lett 285:199-212
122. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Kronke M, Mak TW (1993) Mice deficient for the 55 kDa tumor necrosis factor receptor are resistant to endotoxic shock yet succumb to L monocytogenes infection. Cell 73:457-467
123. Erickson SL, deSauvage FJ, Kikly K, Carver-Moore K, Pitts-Meek S, Gillett N, Sheehan KC, Schreiber RD, Goeddel DV, Moore MW (1994) Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372:560-563
124. Rothe M, Wong SC, Henzel WJ, Goeddel DV (1994) A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681-692
125. Smith CA, Farrah T, Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 76:959-962
126. Baker SJ, Reddy EP (1996) Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1-9
127. Tewari M, Dixit VM (1996) Recent advances in tumor necrosis factor and CD40 signaling. Curr Opinion Genet Dev 6:39-44
128. Rothe M, Sarma V, Dixit VM, Goeddel DV (1995) TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424-1427
129. Hu HM, O'Rourke K, Boguski MS, Dixit VM (1994) A novel RING finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem 269:30069-30072
130. Sato T, Irie S, Reed JC (1995) A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett 358:113-118
131. Cheng G, Cleary AM, Ye ZS, Hong DI, Lederman S, Baltimore D (1995) Involvement of CRAF1, a relative of TRAF in CD40 signaling. Science 267:1494-1498
132. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D (1995) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270:7795-7798
133. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505-512
134. Hsu H, Xiong J, Goeddel DV (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81:495-504
135. Stanger BZ, Leder P, Lee TH, Kim E, Seed B (1995) RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81: 513-523
136. Cleveland JL, Ihle JN (1995) Contenders in FasL/TNF death signaling. Cell 19:479-482
137. Hsu H, Shu HB, Pan MG, Goeddel DV (1996) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84: 299-308
138. Feinstein E, Kimchi A, Wallach D, Boldin M, Varfolomeev E (1995) The death domain: a module shared by proteins with diverse cellular functions. Trends Biochem Sci 20:342-344
139. Cao Z, Henzel WJ, Gao X (1996) IRAK: a kinase associated with the interleukin-1 receptor. Science 271:1128-1131
140. Kolesnick R, Golde DW (1994) The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77:325-328
141. Sehütze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Krönke M (1992) TNF activates NF-κB by phosphatidyl-choline-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71:765-776
142. Yang Z, Costanzo M, Golde DW, Kolesnick RN (1993) Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappa B translocation in intact HL-60 cells. J Biol Chem 268:20520-20523
143. Wiegmann K, Schütze S, Machleidt T, Witte D, Krönke M (1994) Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78:1005-1015
144. Machleidt T, Wiegmann K, Henkel T, Schutze S, Baeuerle PA, Krönke M (1994) Sphingomyelinase activates proteolytic IκBα degradation in a cell-free system. J Biol Chem 269:13760-13765
145. Dressler KA, Mathias S, Kolesnick RN (1992) Tumor necrosis factor alpha activates the sphingomyelin signal transduction pathway in a cell free system. Science 255:1715-1718
146. Müller G, Ayoub M, Storz P, Rennecke J, Fabbro D, Pfitzenmaier (1995) PKC zeta is a molecular switch in signal transduction of TNFα bifunctionally regulated by ceramide and arachidonic acid. EMBO J 14:1961-1969
147. Sun S C, Ganchi PA, Ballard DW, Greene WC (1993) NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 259:1912-1915
148. Scott ML, Fujita T, Liou HC, Nolan GP, Baltimore D (1993) The p65 subunit of NF-κB regulates IκB by two distinct mechanisms. Genes Dev 7:1266-1276
149. Ten RM, Paya CV, Israel N, LeBail O, Mattei MG, Virelizier JL, Kourilsky P, Israel A (1992) The characterization of the promoter of the gene encoding the p50 subunit of NF-κB indicates that it participates in its own regulation. EMBO J 11:195-203
150. Cogswell PC, Scheinman RI, Baldwin AS Jr. (1993) Promoter of the human NF-κB p50/p105 gene: regulation by NF-κB subunits and by c-rel. J Immunol 150:2794-2804
151. Liptay S, Schmid RM, Nabel EG, Nabel GJ (1994) Transcriptional regulation of NF-κB2: evidence for kappa B-mediated positive and negative autoregulation. Mol Cell Biol 14:7695-7703
152. LeBail O, Schmidt-Ullrich R, Israel A (1993) Promoter analysis of the gene encoding the IκB/MAD-3 inhibitor of NF-κB: positive regulation by mebers of the rel/NF-κB family. EMBO J 12:5043-5048
153. Ito CY, Kazantsev AG, Baldwin AS Jr (1994) Three NF-κB sites in the IκBα promoter are required for induction of gene expression by TNFα. Nucl Acids Res 22:3787-3792
154. Hannink M, Temin HM (1990) Structure and autoregulation of the c-rel promoter. Oncogene 5:1843-1850
155. Ueberla K, Lu YC, Chung E, Haseltine WA (1993) The NF-κB p65 promoter. J AlDS Res 6:227-230
156. Perez P, Lira SA, Bravo R (1995) Overexpression of RelA in transgenic mouse thymocytes: specific increase in levels of the inhibitor protein IκBα. Mol Cell Biol 15:3523-3530
157. Hohmann H-P, Remy R, Scheidereit C, van Loon APGM (1991) Maintenance of NF-κB activity is dependent on protein synthesis and the continuous presence of external stimuli. Mol Cell Biol 11:259-266
158. Arenzana-Seisdedos F, Thompson J, Rodriguez MS, Bachelerie F, Thomas D, Hay RT (1995) Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding activities of NF-κB. Mol Cell Biol 15:2689-2696
159. Beg AA, Sha W C, Bronson R T, Baltimore D (1995) Constitutive activation, enhanced granulopoiesis and neonatal lethality in IκBα-deficient mice. Genes Dev 9:2736-2746
160. Ray A, Prefontaine KE (1994) Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc Natl Acad Sci USA 91:752-756
161. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286-290
162. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin A S Jr (1995) Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol Cell Biol 15:943-953
163. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr (1995) Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270:283-286
164. Lee JW, Choi HS, Gyuris J, Brent R, Moore DD (1995) Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol Endocrinol 9:243-254
165. Ray A, Prefontaine KE, Ray P (1994) Down-modulation of interleukin-6 gene expression by 17β-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem 269:12940-12946
166. Stein B, Yang MX (1995) Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ. Mol Cell Biol 15:4971-4979
167. Sha WC, Liou HC, Tuomanen EI, Baltimore D (1995) Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321-330
168. Lernbecher T, Muller U, Wirth T (1993) Distinct NF-κB/Rel transcription factors are responsible for tissue specific and inducible gene activation. Nature 365:767-770
169. Lernbecher T, Kistler B, Wirth T (1994) Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. EMBO J 13:4060-4069
170. Burkly L, Hession C, Ogata L, Reilly C, Marconi L A, Olson D, Tizard R, Cate R, Lo D (1995) Expression of RelB is required for the development of the thymic medulla and dendritic cells. Nature 373:531-536
171. Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck RP,Lira SA, Bravo R (1995) Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80:331-340
172. Liou HC, Sha WC, Scott ML, Baltimore D (1994) Sequential induction of NF-κB/Rel family proteins during B cell terminal differentiation. Mol Cell Biol 14:5349-5359
173. Miyamoto S, Schmitt MJ, Verma IM (1994) Qualitative changes in the subunit composition of κB-binding complexes during murine B-cell differentiation. Proc Natl Acad Sci USA 91:5056-5060
174. Grumont RJ, Gerondakis S (1994) The subunit composition of NF-κB complexes changes during B cell development. Cell Growth Differ 5:1321-1331
175. Tan T-H, Huang GP, Sica A, Ghosh P, Young HA, Longo DL, Rice NR (1992) κB-site dependent activation of the interleukin-2 receptor α-chain gene promoter by human c-rel. Mol Cell Biol 12:4067-4075
176. Kontgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D, Gerondakis S (1995) Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev 9: 1965-1977
177. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D (1995) Embryonic lethality and liver degeneration in mice lacking the ReIA component of NF-κB. Nature 376:167-170
178. Cressman DE, Greenbaum LE, Haber BA, Taub R (1994) Rapid activation of post-hepatectomy factor/nuclear factor kappa B in hepatocytes: a primary response in the regenerating liver. J Biol Chem 269:30429-30435
179. Boehmelt G, Madruga J, Dorfler P, Briegel K Schwarz H, Enrietto PJ, Zenke M (1995) Dendritic cell progenitor is transformed by a conditional v-Rel estrogen receptor fusion protein v-RelER. Cell 80:341-352
180. Mosialos G, Hamer P, Capobianco AJ, Laursen RA, Gilmore TD (1991) A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel. Mol Cell Biol 11:5867-5877
181. Bose HR Jr (1992) The Rel family: models for transcriptional regulation and oncogenic transformation. Biochim Biophys Acta 1114:1-11117
182. Walker WH, Stein B, Ganchi PA, Hoffman JA, Kaufman PA, Ballard DW, Hannink M, Greene WC (1992) The v-rel oncogene: insights into the mechanism of transcriptional activation, repression and transformation. J Virol 66:5018-5029
183. Schatzle JD, Kralova J, Bose HR Jr (1995) Avian IκBα is transcriptionally induced by c-Rel and v-Rel with different kinetics. J Virol 69:5383-5390
184. Hrdlickova R, Nehyba J, Humphries EH (1994) v-rel induces expression of three avian immunoregulatory surface receptors more efficiently than c-rel. J Virol 68:308-319
185. Sarkar S, Gilmore TD (1993) Transformation by the v-Rel oncoprotein requires sequences carboxy-terminal to the Rel homology domain. Oncogene 8:2245-2252
186. Morrison LE, Boehmelt G, Enrietto PJ (1992) Mutations in the Rel-homology domain alter the biochemical properties of v-rel and render it transformation defective in chicken embryo fibroblasts. Oncogene 7:1137-1147
187. Capobianco AJ, Chang D, Mosialos G, Gilmore TD (1992) p105, the NF-κB p50 precursor protein, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells. J Virol 66:3758-3767
188. Hrdlickova R, Nehyba J, Bose HR Jr (1995) Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered κB DNA-binding complexes in transformed cells. J Virol 69:3369-3380
189. Abbadie C, Kabrun N, Bouali F, Smardova J, Stehelin D, Vandenbunder B, and Enrietto PJ (1993) High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell 75:899-912
190. White DW, Roy A Gilmore TD (1995) The v-Rel oncoprotein blocks apoptosis and proteolysis of IκBα in transformed chicken spleen cells. Oncogene 10:857-868
191. Lu D, Thompson JD, Gorski GK, Rice NR, Mayer MG, Yunis JJ (1991) Alterations at the rel locus in human lymphoma. Oncogene 6:1235-12-41
192. Houldsworth J, Mathew S, Rao PH, Dyomina K, Louie DC, Parsa N, Offit K, Chaganti RSK (1996) Rel proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood 87:25-29
193. Ruben SM, Narayanan R, Klement JF, Chen CH, Rosen CA (1992) Functional characterization of the NF-κB p65 transcriptional activator and an alternatively spliced derivative. Mol Cell Biol 12:444-454
194. Narayanan R, Klement JF, Ruben SM, Higgins KA, Rosen CA (1992) Identification of a naturally occurring variant of the p65 subunit of NF-κB. Science 256:367-370
195. Grimm S, Baeuerle PA (1994) Failure of the splicing variant p65 delta of the NF-κB subunit p65 to transform fibroblasts. Oncogene 9:2391-2398
196. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J 9:899-909
197. Higgins KA, Perez JR, Coleman TA, Dorshkind K, McComas WA, Sarmiento UM, Rosen CA, Narayanan R (1993) Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression. Proc Natl Acad Sci USA 90:9901-9905
198. Narayanan R, Higgins KA, Perez JR, Coleman TA, Rosen CA (1993) Evidence for differential functions of the p50 and p65 subunits of NF-κB with a cell adhesion model. Mol Cell Biol 13:3802-3810
199. Kitajima I, Shinohara T, Bilakovics J, Brown DA, Xu X, Nerenberg M (1992) Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-κB. Science 258:1792-1795
200. Tozawa K, Sakurada S, Kohri K, Okamoto T (1995) Effects of anti-nuclear factor κB reagents in blocking adhesion of human cancer cells to vascular endothelial cells. Cancer Res 55:4162-4167
201. Bargou RC, Leng C, Krappmann D, Mapara MY, Daniel PT, Bommert K, Scheidereit C, Dörken B (1996) High level nuclear NF-κB and Oct-2 activity are characteristic for Hodgkin's disease tumor cells. Blood (in press)
202. Beauparlant P, Kwan I, Bitar R, Chou P, Koromilas AE, Sonenberg N, Hiscott J (1994) Disruption of IκBα regulation by antisense RNA expression leads to malignant transformation. Oncogene 9:3189-3197
203. Ghosh P, Sica A, Young HA, Ye J, Franco JL, Wiltrout RH, Longo DL, Rice NR, Komschlies KL (1994) Alterations in NF-κB/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy. Cancer Res 54:2969-2972
204. Li X, Liu J, Park JK, Hamilton TA, Rayman P, Klein E, Edinger M, Tubbs R, Bukowski R, Finke J (1994) T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary report. Cancer Res 54:5424-5429
205. Jung M, Zhang Y, Lee S, Dritschilo A (1995) Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated IκBα. Science 268:1619-1621
206. Savitzky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, et al. (1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753
207. Rabbitts TH (1994) Chromosomal translocations in human cancer. Nature 372:143-149
208. Yano T, Sunder CA, Andrade RE, Gauwerky CE, Croce CM, Longo DL, Jaffe ES, Raffeld M (1993) Molecular analysis of the BCL-3 locus at chomosome 17q22 in B cell neoplasms. Blood 82:1813-1819
209. Bhatia K, Huppi K, McKeithan T, Siwarski D, Mushinski JF, Magrath I (1991) Mouse Bcl-3: cDNA structure, mapping and stage-dependent expression in B lymphocytes. Oncogene 6:1569-1573
210. Caamaño JH, Perez P, Lira SA, and Bravo R (1996) Constitutive expression of Bcl-3 in thymocytes increases the DNA binding of NF-κB1 (p50) homodimers in vivo. Mol Cell Biol 16:1342-1348
211. Pan J, McEver RP (1995) Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-κB/Rel family. J Biol Chem 270:23077-23083
212. Stein J, Mulliken JB, Stal S, Gasser DL, Malcolm S, Winter R, Blanton SH, Amos C, Seemanova E, Hecht JT (1995) Nonsyndromic cleft lip with or without cleft palate: evidence of linkage to Bcl-3 in 17 multigenerational families. Am J Hum Genet 57:257-272
213. Fracchiolla NS, Lombardi L, Salina M, Migliazza A, Baldini L, Berti E, Cro L, Polli E, Maiolo AT, Neri A (1993) Structural alterations of the NF-κB transcription factor lyt-10 in lymphoid malignancies. Oncogene 8:2839-2845
214. Chang CC, Zhang J, Lombardi L, Neri A, Dalla-Favera R (1995) Rearreanged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transaetivators. Mol Cell Biol 15:5180-5187
215. Dejardin E, Bonizzi G, Bellahcène A, Castronovo V, Merville MP, Bours V (1995) Highly expressed p100/p52 (NFKB2) sequesters other NF-κB-related proteins in the cytoplasm of human breast cancer cells. Oncogene 11:1835-1841
216. Mukhopadhyay T, Roth JA, Maxwell SA (1995) Altered expression of the p50 subunit of the NF-κB transcription factor in non-small cell lung carcinoma. Oncogene 11:999-1003
217. Tjian R, Maniatis T (1994) Transcriptional activation: a complex puzzle with few easy pieces. Cell 77:5-8
218. Proud CG (1995) PKR: a new name and new roles. Trends Biochem Sci 6:241-246
219. Thanos D, Maniatis T (1995) Identification of the rel family members required for virus induction of the human beta interferon gene. Mol Cell Biol 15:152-164
220. Thanos D, Maniatis T (1995) Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome. Cell 83:1091-1100
221. Falvo JV, Thanos D, Maniatis T (1995) Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell 83: 1101-1111
222. Kowalik TF, Wing B, Haskill JS, Azizkhan JC, Baldwin AS Jr, Huang ES (1993) Multiple mechanisms are implicated in the regulation of NF-κB activity during human cytomegalovirus infection. Proc Natl Acad Sci USA 90:1107-1111
223. Yurochko AD, Kowalik TF, Huong S-M, Huang ES (1995) Human cytomegalovirus upregulates NF-κB activity by transactivating the NF-κB p105/p50 and p65 promoters. J Virol 69:5391-5400
224. Gribaudo G, Ravaglia S, Gaboli M, Gariglio M, Cavallo R, Landolfo S (1995) Interferon-alpha inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-κB activity. Virology 211:251-260
225. Min W, Ghosh S, Lengyel P (1996) The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-κB, c-Fos and c-Jun activities. Mol Cell Biol 16:359-368
226. Jones KA, Peterlin BM (1994) Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem 63:717-743
227. Roulston A, Lin R, Beauparlant P, Wainberg MA, Hiscott J (1995) Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-κB/Rel transcription factors. Microbiol Rev 59:481-505
228. Nabel G, Baltimore D (1987) An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326:711-713
229. Kretzschmar M, Meisterernst M, Nieters A, Scheidereit C, Li G, Roeder RG (1992) Transcriptional regulation of the HIV-1 promoter by NF-κB in vitro. Genes Dev 6:761-774
230. Alcami J, Lain de Lera T, Folgueira L, Pedraza MA, Jacque JM, Bachelerie F, Noriega AR, Hay RT, Harrich D, Gaynor RB, et al. (1995) Absolute dependence on κB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J 14: 1552-1560
231. Perkins ND, Agranoff AB, Pascal E, Nabel GJ (1994) An interaction between the DNA-binding domains of Re1A (p65) and Sp1 mediates human immunodeficiency virus gene activation. Mol Cell Biol 14:6570-6583
232. Madore SJ, Cullen BR (1995) Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators. Virology 206:1150-1154
233. Bachelerie F, Alcami J, Arenzana Seisdedos F, Virelizier JL (1991) HIV enhancer activity perpetuated by NF-κB induction on infection of monocytes. Nature 350:709-712
234. Zhang D, Zhang N, Wick MM, Byrn RA (1995) HIV Type 1 protease activation of NF-κB within T lymphoid cells. AIDS Res Hum Retroviruses 11:223-230
235. Yamaoka S, Inoue H, Sakurai M, Sugiyama T, Hazama M, Yamada T, Hatanaka M (1996) Constitutive activation of NF-κB is essential for transformation of rat fibroblasts by the human T cell leukemia virus type I Tax. EMBO J 4:873-887
236. Hirai H, Fujisawa J, Suzuki T, Ueda K, Muramatsu M, Tsuboi A, Arai N, Yoshida M (1992) Transcriptional activator Tax of HTLV-1 binds to the NF-κB precursor p105. Oncogene 7:1737-1742
237. Watanabe M, Muramatsu M, Tsuboi A, Aral K (1994) Differential response of NF-κB1 p105 and NF-κB2 p100 to HTLV-I encoded Tax. FEBS Lett 342:115-118
238. Hirai H, Suzuki T, Fujisawa J, Inoue J, Yoshida M (1994) Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor κB and induces nuclear translocation of transcription factor NF-κB proteins for transcriptional activation. Proc Natl Acad Sci USA 91: 3584-3588
239. Munoz E, Courtois G, Veschambre P, Jalinot P, Israel A (1994) Tax induces nuclear translocation of NF-κB through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of IκBα/MAD3. J Virol 68:8035-8044
240. Beraud C, Sun SC, Ganchi P, Ballard DW, Greene WC (1994) Human T-cell leukemia virus type I Tax associates with and is negatively regulated by the NF-κB2 p100 gene product: implications for viral latency. Mol Cell Biol 14: 1374-1382
241. Watanabe M, Muramatsu M, Hirai H, Suzuki T, Fujisawa J, Yoshida M, Arai K, Arai N (1993) HTLV-I encoded Tax in association with NF-κB precursor p105 enhances nuclear localization of NF-κB p50 and p65 in transfected cells. Oncogene 8 2949-2858
242. Murakami T, Hirai H, Suzuki T, Fujisawa J, Yoshida M (1995) HTLV-1 Tax enhances NF-κB2 expression and binds to the products p52 and p100 but does not suppress the inhibitory function of p100. Virology 206:1066-1074
243. Lacoste J, Petropoulos L, Pepin N, Hiscott J (1995) Constitutive phosphorylation and turnover of IκBα in human T-cell leukemia virus type I-infected and Tax-expressing T cells. J Virol 69:564-569
244. Maggirwar SB, Harhaj E, Sun SC (1995) Activation of NF-κB/Rel by Tax involves degradation of IκBα and is blocked by a proteasome inhibitor. Oncogene 5:993-998
245. Rousset R, Desbois C, Bantignies F, Jalinot P (1996) Effects on NF-κB1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome. Nature 381: 328-331
246. Arima N, Molitor JA, Smith MR, Kim JH, Daitoku Y, Greene WC (1991) Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of κB enhancer-binding proteins: evidence for a pretranslational component of regulation. J Virol 65:6892-6899
247. Li CC, Ruscetti FW, Rice NR, Chen E, Yang NS, Mikovits J, Longo DL (1993) Differential expression of Rel family members in human T-cell leukemia virus type I-infected cells: transcriptional activation of c-rel by Tax protein. J Virol 67:4205-4213
248. Khanna R, Burrows SR, Moss DJ (1995) Immune regulation in Epstein Barr virus associated diseases. Microbiol Rev 3:387-405
249. Mitchell T, Sugden B (1995) Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J Virol 69:2968-2976
250. Paine E, Scheinman RI, Baldwin AS, Raab-Traub N (1995) Expression of LMP1 in endothelial cells leads to the activation of a select subset of NF-κB/Rel family proteins. J Virol 69:4572-4576
251. Herrero JA, Mathew P, Paya CV (1995) LMP-1 activates NF-κB by targeting the inhibitory molecule IκBα. J Virol 69:2168-2174
252. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E (1995) The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399